Sort by 'listens'
Understanding ASCENT Clinical Trial for High Risk Smoldering Myeloma Patients
This is the first of a 3 part series of talk on high risk smoldering myeloma and its treatments. Smoldering multiple myeloma (SMM) is an asymptomatic clonal plasma cell disorder. There have been major advances in the diagnosis, prognosis, and…
Allogeneic Transplants for Multiple Myeloma with Dr. Bensinger
March is Myeloma Awareness month and we are exploring the allo transplant therapy route for myeloma patients in our talk with Dr. Bensinger. Why are allogeneic stem cell transplants risky for multiple myeloma patients? When does possible benefit outweigh the…
Immunotherapy Advances in Multiple Myeloma
Recent years have seen the emergence of immunotherapy as a leading form of treatment for multiple myeloma. New strategies such as monoclonal antibody therapies. antibody-drug conjugates, immune checkpoint therapy, adoptive cell therapies such as natural killer cells, marrow infiltrating lymphocytes,…
Patient Advocates: Their Role and Benefits in Clinical Trial Groups
September is Prostate Cancer Awareness month and we are talking to patient advocates to get a better insight into their roles in major clinical groups. Mike Scott is talking to Tony Crispino, patient advocate to the Genitourinary Cancer Section of…
Psychosocial and Emotional Aspects of Infertility w/ Helen Adrienne and Amy Demma
Childlessness due to infertility can be devastating and is on the rise. More and more couples are finding it hard to become pregnant and carry a pregnancy to term. The emotional trauma and hopelessness that come with infertility and recurrent…